Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Avadel Cuts Workforce, Optimizes Cost Structure To Support This

Avadel Pharmaceuticals plc (NASDAQ: AVDL) announced its steps to explore every available pathway to accelerate the FDA approval of its lead drug candidate, FT218, before June 2023.

Benzinga

Xerox Names COO Steve Bandrowczak As Interim CEO After John Visentin Dies Due To Ongoing Illness

Xerox Holdings Corp (NASDAQ:XRX) CEO John Visentin abruptly passed away on June 29 due to complications from an ongoing illness. Since joining Xerox in May 2018, John has been known for his "One Boat, One Team" call to action and mentality. COO Steve Bandrowczak will serve as interim CEO. Xerox registered a first-quarter FY22 sales…

Benzinga

Canopy Growth Enters Into Exchange Agreements With Holders Of Approximately $198M Of Convertible Notes

Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) has entered into privately negotiated exchange agreements with a limited number of holders, including Constellation Brands, Inc. (NYSE: STZ) through its wholly-owned s

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Coinbase To Merge USD, USDC Order Books For 'Deeper Liquidity'

Crypto exchange Coinbase Global Inc (NASDAQ: COIN) plans to merge its U.S. dollar order book with its USD Coin (CRYPTO: USDC) order book.

Benzinga

Nexstar Nears Deal To Snap Majority Control In CW Network: WSJ

Nexstar Media Group, Inc (NASDAQ:NXST) is on the verge of acquiring majority control of the CW Network from Warner Bros. Discovery, Inc (NASDAQ:WBD) and Paramount Global (NASDAQ:PARA), the Wall Street Journal reports. The leading owner of local television stations would acquire 75% of the CW, a broadcast network aimed primarily at teens and young adults, with…

Benzinga

AstraZeneca Says Imfinzi/Chemo Combo Shows Promising Action In Late-Stage Lung Cancer Study

AstraZeneca Plc (NASDAQ:AZN) announced high-level results from a planned interim analysis of the AEGEAN Phase 3 trial of Imfinzi (durvalumab) combined with neoadjuvant chemotherapy in patients with resectable non-small cell lung cancer (NSCLC). The data showed that Imfinzi plus neoadjuvant chemo before surgery demonstrated a statistically significant and meaningful improvement in pathologic complete…

Benzinga

Why Sanofi Shares Are Falling Today

The FDA has placed Sanofi SA's (NASDAQ:SNY) Phase 3 studies of tolebrutinib in multiple sclerosis and myasthenia gravis on partial clinical hold. New enrollment in the U.S. is paused, and participants in the U.S. who have been in the trial for fewer than 60 days shall suspend the study drug. The participants who…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Read How Avid Bioservices Fared In Q4

Avid Bioservices Inc (NASDAQ:CDMO) reported Q4 FY22 sales of $31.2 million, up 13% Y/Y, beating the consensus of $28.96 million. The growth is attributed to an increase in the scope of in-process and completed manufacturing runs and process development revenues. The company signed multiple new project orders during Q4 totaling approximately $44…

Benzinga

iPhone Turns 15: How Much Return $100 Investment In Apple Stock At Launch Would Have Fetched For You

The first iPhone was put on sale by Apple Inc (NASDAQ: AAPL) 15 years ago.

Benzinga

Elon Musk's Giga Texas Worries May Ease As Tesla Factory Said To Significantly Ramp Up Output

Tesla Inc (NASDAQ: TSLA) has been able to ramp up production at Giga Texas to thousands of units per week, Electrek reported&nbs

Benzinga

Aspen Aerogels And 28 Stocks Moving Premarket

Gainers

Benzinga

MillerKnoll Q4 Earnings Beat Street View

MillerKnoll Inc (NASDAQ:MLKN) reported fourth-quarter FY22 sales growth of 77% year-on-year to $1.10 billion, beating the consensus of $1.09 billion. Orders in Q4 rose 47% to $1.01 billion. The gross margin for the quarter contracted 160 basis points Y/Y to 34.8%. The operating expenses rose 51.5% Y/Y to $325.5 million. The operating margin…

Benzinga

Angion Biomedica Pulls The Plug On Another Kidney Disease Trial - Read Why

Angion Biomedica Corp (NASDAQ:ANGN) has discontinued the JUNIPER Phase 2 trial of ANG-3070, an oral tyrosine kinase inhibitor, in primary proteinuric kidney diseases, specifically focal segmental glomerulosclerosis and immunoglobulin A nephropathy. The trial began enrolling patients in December 2021. A reassessment was conducted following a potential safety signal of an unexpected and substantial…

Benzinga

US Stock Futures Down Ahead Of Jobless Claims Data

Pre-open movers

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

InsideEVs

Polestar Shares Down 25 Percent Four Days After Nasdaq Debut

Polestar rang the Nasdaq opening bell on June 28.

Benzinga

This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.

Benzinga

Why China's JD Is Giving Rival Tech Giant Tencent An Additional $220M Stake

Chinese e-commerce giant JD.Com Inc (NASDAQ: JD) on Wednesday said that it renewed its strategic cooperation agreement with the tech and gaming giant Tencent Holdings (OTC: TCEHY) for a period of three years.

Benzinga

Coinbase Provides Crypto Geo Tracking Data To Homeland Security's ICE: Report

Cryptocurrency exchange Coinbase Global Inc (NASDAQ: COIN) is reportedly selling the Immigrations and Customs Enforcement (ICE) data that aids in tracing cryptocurrency transactions.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Your Apple Card Can Help Get Discounts On Ray-Bans, Crocs Sandals

Users of Apple Card, a credit card from Apple Inc (NASDAQ: AAPL), can get 4% Daily Cash on online or in-app purchases on spending at StubHub, Crocs, Ray-Ban, and more.

Benzinga

Amid 'Existential Priority,' Coinbase Seeks To Accelerate Europe Expansion

San Francisco-based cryptocurrency exchange Coinbase Global Inc (NASDAQ: COIN) is reportedly doubling down on its overseas expansion, registering in markets including Italy, Spa

Benzinga

Spirit Airlines Defers Key Shareholder Vote On Frontier Deal Again

Spirit Airlines Inc (NYSE: SAVE) on Wednesday postponed a key shareholder vote on a proposed deal with Frontier Group Holding Inc (NASDAQ: ULCC) until next week.

Benzinga

Exclusive: Golden Matrix Looks To Esports Wagering, Acquisitions To Continue Growth As Core Business Posts 15 Straight Quarters Of Profitability

A new peer-to-peer system for betting in the esports industry is among the growth items for gaming technology company Golden Matrix Group (NASDAQ: GMGI).

Benzinga

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $19,000 Today

Lululemon Athletica (NASDAQ:LULU) has outperformed the market over the past 15 years by 15.34% on an annualized basis producing an average annual return of 21.64%. Currently, Lululemon Athletica has a market capitalization of $36.12 billion.

Benzinga

Here's How Much You Would Have Made Owning Lam Research Stock In The Last 5 Years

Lam Research (NASDAQ:LRCX) has outperformed the market over the past 5 years by 15.15% on an annualized basis producing an average annual return of 24.54%. Currently, Lam Research has a market capitalization of $59.24 billion.

Benzinga

Expert Ratings for Plug Power

Plug Power (NASDAQ:PLUG) has observed the following analyst ratings within the last quarter:

1 … 391 392 393 394

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Warner Bros Discovery

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.